Peter Alan Chambre

Biography

 Mr. Peter Alan Chambre has been a Consultant of 3i Group plc since September 2007. Mr. Chambre served as the Chief Executive Officer of MedImmune Limited from April 2002 to June 2006. He served as the Chief Operating Officer of Celera Genomics Group/Celera Corporation. He served as the Chief Executive Officer of Oxford GlycoSciences Plc and Consort Medical plc. He also served as the Chief Executive Officer of Bespak PLC. He held positions at Bain & Company, Inc., Unilever PLC and Applied Biosystems, Inc. He served as the Chief Executive Officer of Cambridge Antibody Technology Group plc since 2002 until its acquisition by AstraZeneca in 2006.

Research Interest

 Business and Management.